Rallybio Corp.(RLYB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RLYB Rallybio Corp.

盘后交易 06-16 19:58:01 EDT

15.90

+0.00

0.00%

盘后15.81

-0.09-0.57%

17:30 EDT

最高16.00	最低15.77	成交量2.01万
今开15.83	昨收15.90	日振幅1.42%
总市值8,424万	流通市值6,590万	总股本529.81万
成交额31.92万	换手率0.48%	流通股本414.46万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RLYB","market":"US","secType":"STK","nameCN":"Rallybio Corp.","latestPrice":15.9,"timestamp":1781640000000,"preClose":15.9,"halted":0,"volume":20101,"hourTrading":{"tag":"盘后","latestPrice":15.81,"preClose":15.9,"latestTime":"17:30 EDT","volume":14,"amount":221.79000200000002,"timestamp":1781645401214,"change":-0.09,"changeRate":-0.00566,"amplitude":0.00566},"delay":0,"changeRate":0,"floatShares":4144571,"shares":5298100,"eps":-1.384169,"marketStatus":"盘后交易","change":0,"latestTime":"06-16 19:58:01 EDT","open":15.83,"high":15.995,"low":15.77,"amount":319225.930797,"amplitude":0.014151,"askPrice":16.37,"askSize":1,"bidPrice":15.81,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-1.384169,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1781654400000},"marketStatusCode":4,"adr":0,"listingDate":1627531200000,"exchange":"NASDAQ","adjPreClose":15.9,"postHourTrading":{"tag":"盘后","latestPrice":15.81,"preClose":15.9,"latestTime":"17:30 EDT","volume":14,"amount":221.79000200000002,"timestamp":1781645401214,"change":-0.09,"changeRate":-0.00566,"amplitude":0.00566},"volumeRatio":0.395823},"requestUrl":"/m/hq/s/RLYB/wiki","defaultTab":"wiki","newsList":[{"id":"1130272403","title":"Rallybio股东在合并后公司持股2.8%，Avenzo股东持股97.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1130272403","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130272403?lang=zh_cn&edition=full","pubTime":"2026-06-01 20:01","pubTimestamp":1780315278,"startTime":"0","endTime":"0","summary":"根据协议安排，交易完成前Rallybio的现有股东将在合并后的新公司中持有约2.8%的股权，而Avenzo的股东则占据高达97.2%的股权份额。这一股权结构凸显了交易双方在合并实体中的相对地位与权重。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RLYB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136133489","title":"Rallybio与Avenzo达成合并协议 推进下一代肿瘤疗法开发 并同步完成2.15亿美元私募融资","url":"https://stock-news.laohu8.com/highlight/detail?id=1136133489","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136133489?lang=zh_cn&edition=full","pubTime":"2026-06-01 20:00","pubTimestamp":1780315253,"startTime":"0","endTime":"0","summary":"Rallybio Corporation与Avenzo Therapeutics宣布签署合并协议，双方将共同致力于推进下一代肿瘤疗法的研发。与此同时，两家公司还成功完成了高达2.15亿美元的同步私募股权融资。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RLYB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617903552","title":"Rallybio Corporation盘中异动 急速拉升5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617903552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617903552?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:45","pubTimestamp":1772635558,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日22时45分，Rallybio Corporation股票出现波动，股价快速拉升5.56%。Rallybio Corporation股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Klotho Neurosciences, Inc.、Edesa Biotech, Inc.涨幅较大，Klotho Neurosciences, Inc.、Onconetix, Inc.、Edesa Biotech, Inc.较为活跃，换手率分别为40.67%、32.41%、27.54%，振幅较大的相关个股有Klotho Neurosciences, Inc.、Edesa Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为28.39%、20.67%、13.00%。Rallybio Corporation公司简介：Rallybio Corp是一家临床阶段的生物技术公司，致力于开发治疗严重罕见疾病的候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304224558a6a29d74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304224558a6a29d74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RLYB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157103245","title":"Rallybio Corp旗下Candid完成超额认购私募融资 总收益突破5.05亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1157103245","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157103245?lang=zh_cn&edition=full","pubTime":"2026-03-02 21:06","pubTimestamp":1772456811,"startTime":"0","endTime":"0","summary":"生物技术公司Rallybio Corp宣布，其关联企业Candid成功完成一轮超额认购且规模扩大的私募融资。本轮融资总收益超过5.05亿美元，反映出市场对该公司发展前景的强烈信心。\n此次融资获得超额认购，最终规模较原计划有所上调。资金的注入将助力Candid加速推进其创新疗法研发进程，为未来业务拓展提供坚实支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RLYB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131448278","title":"Rallybio Corp：交易前股东预计将持有合并后公司约3.65%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1131448278","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131448278?lang=zh_cn&edition=full","pubTime":"2026-03-02 21:03","pubTimestamp":1772456593,"startTime":"0","endTime":"0","summary":"在本次交易完成前，Rallybio Corp. 的现有股东预计将获得合并后新公司约3.65%的股份。这一股权结构安排凸显了交易双方对现有股东权益的考量，同时也为合并后实体的未来发展奠定了所有权基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","RLYB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158867185","title":"Rallybio Corp：合并后公司预计现金余额足以支撑运营至2030年","url":"https://stock-news.laohu8.com/highlight/detail?id=1158867185","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158867185?lang=zh_cn&edition=full","pubTime":"2026-03-02 21:03","pubTimestamp":1772456591,"startTime":"0","endTime":"0","summary":"Rallybio Corp. 宣布，合并后公司在交易完成时的现金余额预计将能够支持其运营活动持续至2030年。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RLYB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614095612","title":"Rallybio Corporation盘中异动 早盘快速拉升5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614095612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614095612?lang=zh_cn&edition=full","pubTime":"2026-02-26 00:28","pubTimestamp":1772036898,"startTime":"0","endTime":"0","summary":"北京时间2026年02月26日00时28分，Rallybio Corporation股票出现波动，股价快速上涨5.83%。截至发稿，该股报6.17美元/股，成交量1.0053万股，换手率0.19%，振幅5.32%。Rallybio Corporation股票所在的生物技术行业中，整体跌幅为0.25%。Rallybio Corporation公司简介：Rallybio Corp是一家临床阶段的生物技术公司，致力于开发治疗严重罕见疾病的候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602260028199541fe4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602260028199541fe4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLYB","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613821422","title":"Rallybio Corporation盘中异动 快速上涨6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613821422","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613821422?lang=zh_cn&edition=full","pubTime":"2026-02-20 22:31","pubTimestamp":1771597900,"startTime":"0","endTime":"0","summary":"北京时间2026年02月20日22时31分，Rallybio Corporation股票出现波动，股价快速拉升6.00%。截至发稿，该股报5.04美元/股，成交量606股，换手率0.01%，振幅0.00%。Rallybio Corporation股票所在的生物技术行业中，整体跌幅为0.24%。Rallybio Corporation公司简介：Rallybio Corp是一家临床阶段的生物技术公司，致力于开发治疗严重罕见疾病的候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220223141a70d9781&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220223141a70d9781&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RLYB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145861202","title":"Rallybio公布Rlyb116一期研究积极数据，显示对末端补体完全且持续的抑制作用","url":"https://stock-news.laohu8.com/highlight/detail?id=1145861202","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145861202?lang=zh_cn&edition=full","pubTime":"2026-02-17 21:01","pubTimestamp":1771333272,"startTime":"0","endTime":"0","summary":"Rallybio Corp.（股票代码：RLYB）今日宣布其候选药物Rlyb116在一期临床研究中取得积极数据。研究结果显示，该药物能够实现对末端补体系统的完全抑制，且抑制作用持久稳定。这一突破性进展为后续开发针对补体介导疾病的创新疗法奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLYB","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606357627","title":"Rallybio Corporation盘中异动 早盘大幅拉升5.74%报0.700美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606357627","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606357627?lang=zh_cn&edition=full","pubTime":"2026-01-27 22:35","pubTimestamp":1769524521,"startTime":"0","endTime":"0","summary":"北京时间2026年01月27日22时35分，Rallybio Corporation股票出现波动，股价大幅上涨5.74%。截至发稿，该股报0.700美元/股，成交量9476股，换手率0.02%，振幅0.00%。Rallybio Corporation股票所在的生物技术行业中，整体涨幅为1.21%。Rallybio Corporation公司简介：Rallybio Corp 是一家临床阶段的生物技术公司，致力于为严重和罕见疾病患者识别和加速开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127223521a6b383b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127223521a6b383b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RLYB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605238505","title":"Rallybio Corporation盘中异动 早盘股价大涨5.56%报0.710美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605238505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605238505?lang=zh_cn&edition=full","pubTime":"2026-01-23 22:31","pubTimestamp":1769178710,"startTime":"0","endTime":"0","summary":"北京时间2026年01月23日22时31分，Rallybio Corporation股票出现异动，股价急速拉升5.56%。截至发稿，该股报0.710美元/股，成交量2663股，换手率0.01%，振幅0.00%。Rallybio Corporation股票所在的生物技术行业中，整体跌幅为0.08%。Rallybio Corporation公司简介：Rallybio Corp 是一家临床阶段的生物技术公司，致力于为严重和罕见疾病患者识别和加速开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123223150a44edc41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123223150a44edc41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLYB","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518859206","title":"Rallybio Corporation盘中异动 快速跳水5.44%报0.704美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518859206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518859206?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:21","pubTimestamp":1741623701,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时21分，Rallybio Corporation股票出现波动，股价大幅下挫5.44%。截至发稿，该股报0.704美元/股，成交量1.644万股，换手率0.04%，振幅4.83%。Rallybio Corporation股票所在的生物技术行业中，整体涨幅为0.34%。Rallybio Corporation公司简介：Rallybio Corp 是一家临床阶段的生物技术公司，致力于为患有严重和罕见疾病的患者寻找并加速生命转化疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311002142a26a6393&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311002142a26a6393&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLYB","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516688076","title":"Rallybio Corporation盘中异动 快速下挫5.58%报0.682美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516688076","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516688076?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:02","pubTimestamp":1741032149,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时02分，Rallybio Corporation股票出现波动，股价大幅下挫5.58%。截至发稿，该股报0.682美元/股，成交量5.1085万股，换手率0.12%，振幅4.96%。Rallybio Corporation股票所在的生物技术行业中，整体涨幅为0.20%。Rallybio Corporation公司简介：Rallybio Corp 是一家临床阶段的生物技术公司，致力于为患有严重和罕见疾病的患者寻找并加速生命转化疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304040229abe68ed3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304040229abe68ed3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RLYB","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514993863","title":"Rallybio Corporation盘中异动 股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514993863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514993863?lang=zh_cn&edition=full","pubTime":"2025-02-27 01:16","pubTimestamp":1740590179,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日01时16分，Rallybio Corporation股票出现波动，股价大幅上涨5.23%。截至发稿，该股报0.737美元/股，成交量1.5532万股，换手率0.04%，振幅1.81%。Rallybio Corporation股票所在的生物技术行业中，整体跌幅为0.05%。Rallybio Corporation公司简介：Rallybio Corp 是一家临床阶段的生物技术公司，致力于为患有严重和罕见疾病的患者寻找并加速生命转化疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227011620a2551cca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227011620a2551cca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLYB","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514016669","title":"Rallybio Corporation盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514016669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514016669?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:35","pubTimestamp":1740497735,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时35分，Rallybio Corporation股票出现异动，股价快速跳水5.23%。截至发稿，该股报0.708美元/股，成交量2.2098万股，换手率0.05%，振幅5.05%。Rallybio Corporation股票所在的生物技术行业中，整体涨幅为0.85%。Rallybio Corporation公司简介：Rallybio Corp 是一家临床阶段的生物技术公司，致力于为患有严重和罕见疾病的患者寻找并加速生命转化疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233535a253965d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233535a253965d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLYB","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513299765","title":"Rallybio Corporation盘中异动 急速拉升7.62%报0.829美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513299765","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513299765?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:04","pubTimestamp":1740150251,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时04分，Rallybio Corporation股票出现异动，股价急速拉升7.62%。截至发稿，该股报0.829美元/股，成交量3717股，换手率0.01%，振幅4.01%。Rallybio Corporation股票所在的生物技术行业中，整体涨幅为0.08%。Rallybio Corporation公司简介：Rallybio Corp 是一家临床阶段的生物技术公司，致力于为患有严重和罕见疾病的患者寻找并加速生命转化疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230412962b8339&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230412962b8339&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLYB","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512148695","title":"Rallybio Corporation盘中异动 早盘股价大涨6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512148695","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512148695?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:18","pubTimestamp":1739978330,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时18分，Rallybio Corporation股票出现波动，股价急速上涨6.00%。截至发稿，该股报0.779美元/股，成交量1.1516万股，换手率0.03%，振幅3.04%。Rallybio Corporation股票所在的生物技术行业中，整体涨幅为0.56%。Rallybio Corporation公司简介：Rallybio Corp 是一家临床阶段的生物技术公司，致力于为患有严重和罕见疾病的患者寻找并加速生命转化疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219231850abd50a78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219231850abd50a78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RLYB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511457510","title":"Rallybio Corporation盘中异动 大幅上涨6.11%报0.769美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511457510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511457510?lang=zh_cn&edition=full","pubTime":"2025-02-14 02:14","pubTimestamp":1739470442,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日02时14分，Rallybio Corporation股票出现异动，股价大幅拉升6.11%。截至发稿，该股报0.769美元/股，成交量2.481万股，换手率0.06%，振幅7.77%。Rallybio Corporation股票所在的生物技术行业中，整体涨幅为0.88%。Rallybio Corporation公司简介：Rallybio Corp 是一家临床阶段的生物技术公司，致力于为患有严重和罕见疾病的患者寻找并加速生命转化疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214021402abcddd8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214021402abcddd8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RLYB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510334599","title":"Rallybio Corporation盘中异动 临近午盘股价大跌6.41%报0.730美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510334599","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510334599?lang=zh_cn&edition=full","pubTime":"2025-02-12 00:30","pubTimestamp":1739291426,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日00时30分，Rallybio Corporation股票出现波动，股价大幅跳水6.41%。截至发稿，该股报0.730美元/股，成交量4.0775万股，换手率0.10%，振幅4.32%。Rallybio Corporation股票所在的生物技术行业中，整体跌幅为1.55%。Rallybio Corporation公司简介：Rallybio Corp 是一家临床阶段的生物技术公司，致力于为患有严重和罕见疾病的患者寻找并加速生命转化疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212003026961f5cb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212003026961f5cb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","RLYB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510894179","title":"Rallybio Corporation盘中异动 急速下挫5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510894179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510894179?lang=zh_cn&edition=full","pubTime":"2025-02-11 04:00","pubTimestamp":1739217625,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日04时00分，Rallybio Corporation股票出现波动，股价大幅下挫5.25%。截至发稿，该股报0.800美元/股，成交量9.2297万股，换手率0.22%，振幅5.92%。Rallybio Corporation股票所在的生物技术行业中，整体跌幅为0.93%。Rallybio Corporation公司简介：Rallybio Corp 是一家临床阶段的生物技术公司，致力于为患有严重和罕见疾病的患者寻找并加速生命转化疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110400259880b68a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110400259880b68a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RLYB"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rallybio.com","stockEarnings":[{"period":"1week","weight":-0.0006},{"period":"1month","weight":0.1119},{"period":"3month","weight":0.6477},{"period":"6month","weight":1.7685},{"period":"1year","weight":5.1343},{"period":"ytd","weight":1.8968}],"compareEarnings":[{"period":"1week","weight":0.0211},{"period":"1month","weight":0.0212},{"period":"3month","weight":0.1253},{"period":"6month","weight":0.1243},{"period":"1year","weight":0.2644},{"period":"ytd","weight":0.1069}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rallybio Corporation于2018年3月22日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，由经验丰富的生物制药行业领导者组成，拥有广泛的研究、开发和罕见疾病专业知识，其使命是为患有严重和罕见疾病的患者开发和商业化改变生命的疗法。自公司于2018年1月推出以来，该公司已经建立了广泛的有前景的候选产品管道，旨在解决孕产妇胎儿健康、补体失调、血液学和代谢紊乱等领域存在未满足医疗需求的疾病。该公司两个最先进的项目正在临床开发中：RLYB212，一种用于预防胎儿和新生儿同种免疫性血小板减少症（“FNAIT”）的抗HPA-1a抗体，以及RLYB116，一种补体成分5（“C5”）的抑制剂，具有治疗几种补体失调疾病的潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.05452},{"month":2,"riseRate":0.6,"avgChangeRate":0.213566},{"month":3,"riseRate":0.2,"avgChangeRate":-0.14957},{"month":4,"riseRate":0.6,"avgChangeRate":-0.020246},{"month":5,"riseRate":0.6,"avgChangeRate":0.227902},{"month":6,"riseRate":0.4,"avgChangeRate":-0.131704},{"month":7,"riseRate":1,"avgChangeRate":0.176338},{"month":8,"riseRate":0.4,"avgChangeRate":-0.034234},{"month":9,"riseRate":0.6,"avgChangeRate":0.045433},{"month":10,"riseRate":0.6,"avgChangeRate":0.040053},{"month":11,"riseRate":0.2,"avgChangeRate":-0.230437},{"month":12,"riseRate":0.6,"avgChangeRate":0.001492}],"exchange":"NASDAQ","name":"Rallybio Corp.","nameEN":"Rallybio Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rallybio Corp.(RLYB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rallybio Corp.(RLYB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rallybio Corp.,RLYB,Rallybio Corp.股票,Rallybio Corp.股票老虎,Rallybio Corp.股票老虎国际,Rallybio Corp.行情,Rallybio Corp.股票行情,Rallybio Corp.股价,Rallybio Corp.股市,Rallybio Corp.股票价格,Rallybio Corp.股票交易,Rallybio Corp.股票购买,Rallybio Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rallybio Corp.(RLYB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rallybio Corp.(RLYB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}